Literature DB >> 7569345

Vitrectomy for vitreomacular traction syndrome with macular detachment.

N S Melberg1, D F Williams, M W Balles, G J Jaffe, T A Meredith, S R Sneed, D J Westrich.   

Abstract

PURPOSE: To describe the clinical characteristics of the vitreomacular traction syndrome with macular detachment and to report our surgical experience with this condition.
METHODS: A retrospective chart and photographic review was performed on nine patients (nine eyes) who had a symptomatic decrease in visual acuity from a macular traction retinal detachment caused by vitreomacular traction syndrome. Vitrectomy was performed in each eye to reattach the retina.
RESULTS: Intraoperative observation confirmed partial posterior vitreous separation with adherence of the posterior hyaloid to the detached retina and separation of the posterior hyaloid from the attached retina. After surgery the macula was reattached in seven eyes (78%). Visual acuity was improved in four eyes, stable in four eyes, and worse in one eye.
CONCLUSION: Macular detachment may occur secondary to vitreomacular traction syndrome. Although the retina may be reattached surgically in these cases, visual improvement may be limited by chronic detachment, premacular fibrosis, cystoid macular edema, or macular schisis.

Entities:  

Mesh:

Year:  1995        PMID: 7569345     DOI: 10.1097/00006982-199515030-00002

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  11 in total

1.  Vitrectomy for macular pucker and vitreomacular traction syndrome.

Authors:  F Koerner; J Garweg
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

2.  Epiretinal pathology of vitreomacular traction syndrome.

Authors:  A Gandorfer; M Rohleder; A Kampik
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

3.  Retinal pigment epithelium detachment associated with vitreomacular traction syndrome-case report.

Authors:  Ilias Georgalas; Catherin Heatley; Eric Ezra
Journal:  Int Ophthalmol       Date:  2008-07-15       Impact factor: 2.031

4.  A novel spectral-domain optical coherence tomography model to estimate changes in vitreomacular traction syndrome.

Authors:  Marco Codenotti; Lorenzo Iuliano; Giovanni Fogliato; Giuseppe Querques; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-25       Impact factor: 3.117

Review 5.  Ocriplasmin for symptomatic vitreomacular adhesion.

Authors:  James E Neffendorf; Varo Kirthi; Edward Pringle; Timothy L Jackson
Journal:  Cochrane Database Syst Rev       Date:  2017-10-17

6.  OCT-guided hyaloid release for vitreomacular traction syndrome.

Authors:  Eun Jee Chung; Young Ju Lew; Hyo Lee; Hyoung Jun Koh
Journal:  Korean J Ophthalmol       Date:  2008-09

7.  Vitreomacular traction syndrome.

Authors:  Juliana Bottós; Javier Elizalde; J Fernando Arevalo; Eduardo B Rodrigues; Maurício Maia
Journal:  J Ophthalmic Vis Res       Date:  2012-04

8.  Ten Years of Severe Vitreomacular Traction Syndrome without Functional Damage Demonstrated by Optical Coherence Tomography.

Authors:  Michele Reibaldi; Teresio Avitabile; Maurizio Giacinto Uva; Francesco Occhipinti; Mario Toro; Marco Zagari; Andrea Russo
Journal:  Case Rep Ophthalmol Med       Date:  2011-09-08

Review 9.  Ocriplasmin for symptomatic vitreomacular adhesion: an evidence-based review of its potential.

Authors:  Su Jeong Song; William E Smiddy
Journal:  Core Evid       Date:  2014-03-21

Review 10.  Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion.

Authors:  Francisco R Stefanini; Maurício Maia; Paulo Falabella; Marcel Pfister; Moritz Niemeyer; Amir H Kashani; Mark S Humayun; Michael J Koss
Journal:  Clin Ophthalmol       Date:  2014-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.